Compared to mice without tumor metastatic, the percentage of CXCR2+ MDSCs in the peripheral blood was higher in mice with lymph node metastasis (76.7 ± 6.0% vs 58.1 ± 2.8%) (Figure 2C). The gene discussed is CXCR2; the disease is neoplasm.